Antibody-Drug Conjugates

Our research aims to investigate new approaches of drug conjugation to mAb and the potential of new hydrophilic linkers able to counterbalance the common high hydrophobicity of drugs, thus allowing higher drug payload.

Key Publications

  2021 - Anti-HER2 ADCs with New PEG Linkers

Tedeschini T, Campara B, Grigoletto A, Bellini M, Salvalaio M, Matsuno Y, Suzuki A, Yoshioka H, Pasut G. Polyethylene glycol-based linkers as hydrophilicity reservoir for antibody-drug conjugates. J Control Release. 2021;337:431-447. doi: 10.1016/j.jconrel.2021.07.041.

Mobirise

  2019 - Non-Covalent ADCs

Maso K, Montagner IM, Grigoletto A, Schiavon O, Rosato A, Pasut G. A non-covalent antibody complex for the delivery of anti-cancer drugs. Eur J Pharm Biopharm. 2019;142:49-60. doi: 10.1016/j.ejpb.2019.06.012

Mobirise